MyMD Pharmaceuticals, Inc.
Method of regulating tumor necrosis factor-alpha (TNF-.alpha.) for treating cancers, autoimmune disorders, and other disorders associated with chronic inflammation

Abstract:

In one aspect, a method of treating a disorder associated with chronic inflammation includes administering to an individual in need thereof a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof. In some aspects, the disorder is a cancer, an autoimmune disorder, hypertension, or autism. In other aspects, isomyosmine is administered to treat viral infections or disorders associated with elevated levels of hydrogen peroxide and/or other Reactive Oxygen Species (ROS).